HOLON, Israel, Feb. 19, 2026 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational drug target discovery powered by AI/ML, today announced that management will participate in the following upcoming investor conferences: Oppenheimer 36th Annual Healthcare Life Sciences Conference Date: Thursday, February 26, 2026 Location: Virtual Format: Fireside chat and 1x1 meetings Fireside chat time: 2 PM ET Leerink Partners 2026 Global Healthcare Conference Date: Monday, March 9, 2026 Location: Miami, Florida, U.S. Format: Fireside chat and 1x1 meetings Fireside chat time: 8:40 AM ET Live webcasts of the fireside chats will be available on the events page of the Investor Relations section of Compugen's website at www.cgen.com.